Serum Immunoglobulins and complement subfactors levels in sodium valproate treated epileptic patients
Objectives: To assess, the serum levels of immunoglobulins (IgG, IgA, IgM) and complement subfactors (C٣, C٤) in newly diagnosed epileptic patients in the pretherapy stage and ٣ months after valproate therapy, in comparison with controls. Methods: This study was conducted at Iben-Seena Hospital and...
Saved in:
Main Authors: | Nazar A-K Hami (Author), Mohammed Khalid Al-Nori (Author), Omer AH Ahmed (Author), Imad Abdul-Jabbar Thanoon (Author) |
---|---|
Format: | Book |
Published: |
University of Mosul,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of serum immunoglobulin and complement components level in patients with pulmonary tuberculosis
by: Imad A.J Thanoon, et al.
Published: (2008) -
Effect of conventional and sustained release sodium valproate on serum leptin and some liver function tests in epileptic patients
by: Sajid Kh Ameen, et al.
Published: (2019) -
Phenylthiocarbamide perception in epileptic patients on carbamazepine therapy
by: Hilmy AS Abdul-Jabbar, et al.
Published: (2011) -
Effect of depot-medroxyprogesterone acetate injections on serum immunoglobulins and complements level
by: Wahda B. Al-Youzbaki
Published: (2008) -
UGT2B7 gene polymorphism and linkage disequilibrium in pediatric epileptic patients and their influence on sodium valproate monotherapy: A cohort study
by: Sachidananda Adiga, et al.
Published: (2022)